Tracee Ridley-Pryor
Psychiatric/Mental Health · Memphis, TNNPI 1164941928
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 59 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 18.6% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,047, 2.1 times the $495 reported in 2021.
Across 59 payments — averaging $62.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$687
- Jazz Pharmaceuticals Inc.$429
- Neurocrine Biosciences, Inc.$414
- Neurelis, Inc.$371
- Axsome Therapeutics, Inc.$347
- Livanova USA, Inc.$228
- plus $1K from 16 others
What the payments were for
- Food & beverage$3,701100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 12 | $687 |
| Jazz Pharmaceuticals Inc. | 4 | $429 |
| Neurocrine Biosciences, Inc. | 4 | $414 |
| Neurelis, Inc. | 6 | $371 |
| Axsome Therapeutics, Inc. | 3 | $347 |
| Livanova USA, Inc. | 4 | $228 |
| Upsher-smith Laboratories LLC | 3 | $149 |
| Nobelpharma America, LLC | 1 | $141 |
| PTC Therapeutics, Inc. | 1 | $125 |
| Tris Pharma Inc | 1 | $124 |
| E.r. Squibb & Sons, L.L.C. | 1 | $123 |
| Teva Pharmaceuticals USA, Inc. | 1 | $103 |
| Seqirus USA Inc | 1 | $87 |
| Zogenix Inc. | 1 | $59 |
| SK Life Science, Inc. | 3 | $56 |
| Eisai Inc. | 3 | $50 |
| Immedica Pharma US, Inc. | 2 | $45 |
| Supernus Pharmaceuticals, Inc. | 1 | $45 |
| Aquestive Therapeutics, Inc. | 3 | $41 |
| Catalyst Pharmaceuticals, Inc. | 2 | $41 |
| Biocodex, Inc. | 1 | $18 |
| Azurity Pharmaceuticals, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INGREZZA$361
- Auvelity$347
- VALTOCO$259
- Epidiolex$244
- Fintepla$208
- Nayzilam$148
- HYFTOR$141
- VNS THERAPY SENTIVA MODEL 1000 GENERATOR$137
- Dyanavel XR$124
- Quillivant$124
- Quillichew ER$124
- COBENFY$123
- AUSTEDO$103
How this compares
$3,701 in reported general payments places this provider in the 85th percentile of 1,167 psychiatric/mental health providers in Tennessee.
Other psychiatric/mental health in Memphis
- Mary AllenMemphis$422K
- Sarah VogelfangerMemphis$94K
- Michael HobbsMemphis$23K
- Angela HammondMemphis$16K
- Kristen LockeMemphis$9K
- Latasha GarrettMemphis$8K
- Lisa WilliamsMemphis$8K
- Kristin FitchpatricMemphis$8K
- Laura MelaroBolivar$682K
- Fay BembryJohnson City$449K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.